| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7f015c7c3b1e8b919f0fa7e816e4ed1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5a41871a39a95e0d3148135c71947ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10045ff5d203204a9248a2d2d8885e94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e021d0c6852d6882424479b78f14879 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2835
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4704 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y603-02019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2011-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_236e29e76c7913dd2ae998a0997ffc71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d565ef07adfb94a047dbdecf77350d9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7872288eb2ddeeb2a3687012bd454408
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e5c7422b7d867c6540b4c09dafe164e |
| publicationDate |
2012-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012067970-A3 |
| titleOfInvention |
Transcriptional repression leading to parkinson's disease |
| abstract |
Methods of diagnosing and identifying small molecules useful in the treatment of Parkinson's disease by measuring the amount of PARIS in a sample are disclosed. Further disclosed are cell lines expressing PARIS. In vitro models of Parkin inactivation using a PARIS inhibitor are further disclosed |
| priorityDate |
2010-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |